188 related articles for article (PubMed ID: 22544570)
1. Expression of TopBP1 in hereditary breast cancer.
Forma E; Krzeslak A; Bernaciak M; Romanowicz-Makowska H; Brys M
Mol Biol Rep; 2012 Jul; 39(7):7795-804. PubMed ID: 22544570
[TBL] [Abstract][Full Text] [Related]
2. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
Starska K; Forma E; Nowacka-Zawisza M; Lewy-Trenda I; Ciesielski P; Pietruszewska W; Skóra M; Bryś M
Tumour Biol; 2016 Apr; 37(4):4541-57. PubMed ID: 26503213
[TBL] [Abstract][Full Text] [Related]
3. Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.
Forma E; Brzeziańska E; Krześlak A; Chwatko G; Jóźwiak P; Szymczyk A; Smolarz B; Romanowicz-Makowska H; Różański W; Bryś M
Mol Biol Rep; 2013 May; 40(5):3493-502. PubMed ID: 23277395
[TBL] [Abstract][Full Text] [Related]
4. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of gynecological oncology--TopBP1 protein and its participation in the transcription process].
Forma E; Wójcik-Krowiranda K; Bieńkiewicz A; Bryś M
Ginekol Pol; 2012 May; 83(5):363-7. PubMed ID: 22708334
[TBL] [Abstract][Full Text] [Related]
6. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.
Yan M; Xu H; Waddell N; Shield-Artin K; Haviv I; ; McKay MJ; Fox SB
Breast Cancer Res; 2012 Apr; 14(2):R69. PubMed ID: 22537934
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
Liu K; Bellam N; Lin HY; Wang B; Stockard CR; Grizzle WE; Lin WC
Mol Cell Biol; 2009 May; 29(10):2673-93. PubMed ID: 19289498
[TBL] [Abstract][Full Text] [Related]
9. PML protein expression in hereditary and sporadic breast cancer.
Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z
Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314
[TBL] [Abstract][Full Text] [Related]
10. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.
Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Jpn J Cancer Res; 2001 Jun; 92(6):624-30. PubMed ID: 11429050
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2.
Jackson SA; Davis AA; Li J; Yi N; McCormick SR; Grant C; Fallen T; Crawford B; Loranger K; Litton J; Arun B; Vande Wydeven K; Sidani A; Farmer K; Sanders M; Hoskins K; Nussbaum R; Esserman L; Garber JE; Kaklamani VG;
Cancer; 2014 May; 120(10):1557-64. PubMed ID: 24522996
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
14. Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.
Karppinen SM; Erkko H; Reini K; Pospiech H; Heikkinen K; Rapakko K; Syväoja JE; Winqvist R
Eur J Cancer; 2006 Oct; 42(15):2647-52. PubMed ID: 16930991
[TBL] [Abstract][Full Text] [Related]
15. New complexities for BRCA1 and BRCA2.
Kerr P; Ashworth A
Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
17.
Jin TY; Park KS; Nam SE; Yoo YB; Park WS; Yun IJ
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409110
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Liu K; Graves JD; Lin FT; Lin WC
J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53.
Morris JS; Nixon C; Bruck A; Nasir L; Morgan IM; Philbey AW
Vet J; 2008 Feb; 175(2):218-26. PubMed ID: 17336111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
